Robert Lambkin-Williams (Rob Lambkin-Williams)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 6

Top Venues

Influenza and other respiratory viruses

PLoS pathogens

PloS one

Respiratory research

VirologyConsult.com

This page only lists publications with an associated author ORCID identifier.

Affiliation History

VirologyConsult.com Jul 19 2019

United Kingdom

Consultant :: Board

hVIVO (United Kingdom)

United Kingdom

Chief Scientific Officer/ Executive Scientific Adviser

Retroscreen Virology (United Kingdom) - Jul 16 2016

United Kingdom

Chief Scientific Officer

Queen Mary, Uni of London and Retroscreen Virology (United Kingdom) May 12 1995

United Kingdom

Founding Scientist through to Chief Executive Officer :: Clinical Science Group

Publications

Paul Jacob Bueno de Mesquita, Jonathan S Nguyen-Van-Tam, Ben Killingley, Joanne Enstone, Robert Lambkin-Williams, Anthony S Gilbert, Alexander Mann, John Forni, Jing Yan, Jovan Pantelic, Michael L Grantham, Donald K Milton
Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases. Influenza and other respiratory viruses 15 (1) (2020)
Robert Lambkin-Williams, John P DeVincenzo
A COVID-19 human viral challenge model. Learning from experience. Influenza and other respiratory viruses 14 (6) (2020)
Robert Lambkin-Williams, Alexander Mann, Adrian Shephard
Inhibition of viral and bacterial trigger-stimulated prostaglandin E2 by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell line. SAGE open medicine 8 (2020)
Robert Lambkin-Williams, Nicolas Noulin, Alex Mann, Andrew Catchpole, Anthony S Gilbert
The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. Respiratory research 19 (1) (2018)
Ashley Sobel Leonard, Micah T McClain, Gavin J D Smith, David E Wentworth, Rebecca A Halpin, Xudong Lin, Amy Ransier, Timothy B Stockwell, Suman R Das, Anthony S Gilbert, Robert Lambkin-Williams, Geoffrey S Ginsburg, Christopher W Woods, Katia Koelle, Christopher J R Illingworth
The effective rate of influenza reassortment is limited during human infection. PLoS pathogens 13 (2) (2017)
Robert Lambkin-Williams, Colin Gelder, Richard Broughton, Corey P Mallett, Anthony S Gilbert, Alex Mann, David He, John S Oxford, David Burt
An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection. PloS one 11 (12) (2016)

Robert Lambkin-Williams.css-eqlu8i{font-size:small;padding-left:4px;} (Rob Lambkin-Williams)

Publication Activity (10 Years)

Top Topics

Top Venues

Robert Lambkin-Williams (Rob Lambkin-Williams)